APLS vs SNA · rev $1.00B vs P/E 17, rev $1.33B
Apellis Pharmaceuticals Inc (APLS) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Latest reported APLS revenue for 2025-12-31 was $1.00B. Net income was $22.4M. Revenue was up 28.5% from 2024-12-31 to 2025-12-31. APLS currently screens at market cap $2.29B.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
APLS currently screens at market cap $2.29B. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the APLS and SNA stock pages for the full models.
Not investment advice.